International Investment Afternoon #2 2020

Mr. David Elsley, MBA, is a business leader with a proven track record of developing, financing, and managing all aspects of corporate development in biotechnology and high-growth organizations. David founded Vasogen Inc., a biotechnology company focused on the research and commercial development of novel therapeutics for the treatment of heart failure and other inflammatory conditions. He assembled a team of management, directors, and scientific advisors comprising industry professionals and thought leaders and managed and directed Vasogen’s growth from start-up to an organization employing over 250 people with operations and R&D programs in Canada, the United States and Europe and a market capitalization of over US$1 billion. Mr. Elsley founded Cardiol Therapeutics in 2017.

Abraham Drost, M.Sc. P.Geo. CEO & Director Mr. Drost is a Professional Geoscientist with a 35-yr career in exploration and development. He is the former President and Director of Sabina Gold and Silver (SBB:TSX). Mr. Drost was the founding CEO of Premier Royalty Inc. (NSR:TSX), and at the sale to Sandstorm Gold. He was a former CEO and then Director of Mega Precious Metals Inc. (MGP:TSXV) at the sale to Yamana. Mr. Drost was most recently CEO and Director of Carlisle Goldfields Ltd. (CGJ:TSX) at the sale to Alamos (AGI:TSX). Previously, Mr. Drost was Regional Land Use Geologist with the Ontario Government and highly attuned to First Nation aspirations in Canada. Jim Gallagher, P.Eng. Executive Chairman Mr. Jim Gallagher, P.Eng. Mr. Gallagher is a Professional Engineer with a 35-year track record of optimizing operational performance. Mr. Gallagher was most recently the President and CEO of North American Palladium Ltd. (“NAP”). During his 6 year tenure at NAP, Mr. Gallagher rebuilt the senior management team, introduced advanced technologies and mining methods at the Lac des Iles Mine and achieved an operational and financial turnaround making the Lac des Illes Mine one of the largest and lowest cost underground mines in Canada, culminating in the 2019 sale of NAP for $1 billion to Impala Platinum. Prior to NAP, Mr. Gallagher spent 24 years with Falconbridge Inc., in a variety of operational and project management roles and eight years as Global Director of Mining for Hatch, leading one of the largest mining EPCM teams in North America. Mr. Gallagher is currently the chair of the technical committee on the board of Directors for Harte Gold and also serves on the board of the Ontario Mining Association.

Dr. Torrens is a 25-year healthcare and education entrepreneur. A 2x Inc 5000 Honoree, he is experienced in leading high growth companies, raising capital, and M&A (buy and sell side). Dr. Torrens has a Ph.D. in healthcare administration and did his dissertation on reimbursement and utilization of telehealth services. He holds a faculty position in the Syracuse University Whitman School of Management’s Department of Entrepreneurship and Emerging Enterprises as an award winning Professor of Entrepreneurial Practice. He is an active member of Young Presidents Organization (YPO) and served in multiple volunteer leadership positions including a term on the International Board of Directors (2013-2015).